Literature DB >> 23053753

Short-term alendronate treatment does not maintain a residual effect on spinal fusion with interbody devices and bone graft after treatment withdrawal: an experimental study on spinal fusion in pigs.

Baoding Huang1, Xuenong Zou, Haisheng Li, Qingyun Xue, Cody Bünger.   

Abstract

PURPOSE: Whether alendronate treatment has a residual effect on bone ingrowth into porous biomaterial in humans or experimental animals after treatment withdrawal is still unknown. The purpose of this study was to investigate bone ingrowth into porous tantalum and carbon fiber interbody implants after discontinuing alendronate treatment in experimental spinal fusion in pigs.
METHODS: Twenty-four pigs were randomly divided into two groups of each 12 pigs. The pigs underwent anterior intervertebral lumbar arthrodeses at L2-3, L4-5 and L6-7. Each level was randomly allocated to one of the three implants: a porous tantalum ring with pedicle screw fixation, a porous tantalum ring or a carbon fiber cage with anterior staple fixation. The central hole of implants was packed with an autograft. Alendronate was given orally for the first 3 months to one of the two groups. The pigs were observed for 6 months postoperatively. Histology and micro-CT scans were done at the endpoint.
RESULTS: The spinal fusion rates of each implant showed no differences between two treatment groups. Furthermore, no differences were found between two groups as for bone ingrowth into the central holes of implants and bone-implant interface in each implant, or as for the pores of tantalum implants. Trabecular bone microarchitecture in the central hole of the carbon fiber cage did not differ between two treatment groups.
CONCLUSION: The application of ALN, with a dose equivalent to that given to humans during the first 3 months after surgery, does not maintain a residual effect on spinal fusion with porous tantalum ring and autograft after treatment withdrawal in a porcine ALIF model.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23053753      PMCID: PMC3555615          DOI: 10.1007/s00586-012-2513-7

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


  21 in total

1.  Characteristics of bone ingrowth and interface mechanics of a new porous tantalum biomaterial.

Authors:  J D Bobyn; G J Stackpool; S A Hacking; M Tanzer; J J Krygier
Journal:  J Bone Joint Surg Br       Date:  1999-09

2.  Accuracy of cancellous bone volume fraction measured by micro-CT scanning.

Authors:  M Ding; A Odgaard; I Hvid
Journal:  J Biomech       Date:  1999-03       Impact factor: 2.712

3.  Tissue response to porous tantalum acetabular cups: a canine model.

Authors:  J D Bobyn; K K Toh; S A Hacking; M Tanzer; J J Krygier
Journal:  J Arthroplasty       Date:  1999-04       Impact factor: 4.757

4.  Alendronate therapy may be effective in the prevention of bone loss around titanium implants inserted in estrogen-deficient rats.

Authors:  Poliana Mendes Duarte; Bruno César de Vasconcelos Gurgel; Antonio Wilson Sallum; Getúlio Rocha Nogueira Filho; Enilson Antonio Sallum; Francisco Humberto Nociti
Journal:  J Periodontol       Date:  2005-01       Impact factor: 6.993

5.  Interbody cage stabilisation in the lumbar spine: biomechanical evaluation of cage design, posterior instrumentation and bone density.

Authors:  T Lund; T R Oxland; B Jost; P Cripton; S Grassmann; C Etter; L P Nolte
Journal:  J Bone Joint Surg Br       Date:  1998-03

6.  Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.

Authors:  U A Liberman; S R Weiss; J Bröll; H W Minne; H Quan; N H Bell; J Rodriguez-Portales; R W Downs; J Dequeker; M Favus
Journal:  N Engl J Med       Date:  1995-11-30       Impact factor: 91.245

7.  High-dose alendronate uncouples osteoclast and osteoblast function: a study in a rat spine pseudarthrosis model.

Authors:  Andrew A Sama; Safdar N Khan; Elizabeth R Myers; Russel C Huang; Frank P Cammisa; Harvinder S Sandhu; Joseph M Lane
Journal:  Clin Orthop Relat Res       Date:  2004-08       Impact factor: 4.176

8.  The effect of alendronate sodium on spinal fusion: a rabbit model.

Authors:  Ronald A Lehman; Timothy R Kuklo; Brett A Freedman; Jerry R Cowart; Mark G Mense; K Daniel Riew
Journal:  Spine J       Date:  2004 Jan-Feb       Impact factor: 4.166

9.  Effect of alendronate on bone ingrowth into porous tantalum and carbon fiber interbody devices: an experimental study on spinal fusion in pigs.

Authors:  Xuenong Zou; Qingyun Xue; Haisheng Li; Mathias Bünger; Martin Lind; Cody Bünge
Journal:  Acta Orthop Scand       Date:  2003-10

10.  Effect of alendronate on fracture healing and bone remodeling in dogs.

Authors:  C P Peter; W O Cook; D M Nunamaker; M T Provost; J G Seedor; G A Rodan
Journal:  J Orthop Res       Date:  1996-01       Impact factor: 3.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.